Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empiric vs Selective Medical Therapy for Calcium Oxalate Stone Prevention
NCT07225764Phase 4Recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorthalidone in nephrolithiasis, sponsored by Icahn School of Medicine at Mount Sinai. Started Oct 2025; status: recruiting.
02
Drugs
chlorthalidone
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT07225764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07225764.